Treating dyslipidemia to slow the progression of chronic renal failure.
作者信息
Palmer Biff F, Alpern Robert J
出版信息
Am J Med. 2003 Apr 1;114(5):411-2. doi: 10.1016/s0002-9343(03)00070-6.
Abstract
摘要
相似文献
1
Treating dyslipidemia to slow the progression of chronic renal failure.
Am J Med. 2003 Apr 1;114(5):411-2. doi: 10.1016/s0002-9343(03)00070-6.
2
[The significance of hypolipemic drugs in the inhibition of progression of renal failure].
Pol Arch Med Wewn. 2002 Apr;107(4):369-74.
3
Should hyperlipidaemia in dialysis patients be treated?
Nephrol Dial Transplant. 1997 Jan;12(1):19-21. doi: 10.1093/ndt/12.1.19.
4
[Monitoring and treatment of dyslipidemia in predialysis patients with chronic renal failure].
Pol Arch Med Wewn. 2003 Oct;110(4):1215-25.
5
Optimization of hypolipidemic and antiplatelet treatment in the diabetic patient with renal disease.
J Am Soc Nephrol. 2004 Jan;15 Suppl 1:S12-20. doi: 10.1097/01.asn.0000093238.09114.40.
6
Cardiovascular risk in patients with renal disease: treating the risk or treating the risk factor?
Nephrol Dial Transplant. 2004 Jan;19(1):23-6. doi: 10.1093/ndt/gfg421.
7
[Dyslipidemia in renal failure].
Nihon Rinsho. 2004 Jun;62 Suppl 6:118-23.
8
Hyperlipidemia and its management in renal disease.
Curr Opin Nephrol Hypertens. 1996 Mar;5(2):141-6. doi: 10.1097/00041552-199603000-00007.
9
Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management.
Curr Opin Pediatr. 2002 Apr;14(2):197-204. doi: 10.1097/00008480-200204000-00009.
10
Therapeutic strategies to slow chronic kidney disease progression.
Pediatr Nephrol. 2008 May;23(5):705-16. doi: 10.1007/s00467-008-0789-y. Epub 2008 Mar 12.
Zotero 插件